STOCK TITAN

Scientific Industries (SCND) 10-K Filings

SCND OTC

Here are the 10-K annual reports from Scientific Industries Inc (SCND) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow SCND and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SCND filings page.

Rhea-AI Summary

Scientific Industries, Inc. reported full-year 2025 results, highlighted by the sale of its Genie benchtop product line and continued investment in bioprocessing. Net revenues rose to $5,053,800, driven mainly by Torbal weighing products, while dependence on a single pill-counter customer remained high.

The company posted a net loss of $1,220,400, a substantial improvement from 2024 as it recorded a $5,263,400 gain on the Genie sale and reduced general, selling, and R&D expenses. However, gross margin fell to 25.8% due to bioprocessing inventory write-offs.

Cash and equivalents were $955,000 at year-end, with an accumulated deficit of $35,150,900. Management expects existing cash plus proceeds and earn-outs from the Genie transaction to fund operations for at least one year while it pursues growth in its Bioprocessing Systems segment.